Kimberly-Clark Corporation
NASDAQCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Michael D. Hsu
- Full Time Employees
- 36,000
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Address
- PO Box 619100 Dallas TX United States of America 75261-9100
- IPO Date
- Mar 17, 1980
- CIK
- 0000055785
- Website
- kimberly-clark.com
- Similar Companies
- Business
- Kimberly-Clark Corporation manufactures and markets a broad range of personal care, consumer tissue, and professional products made from natural or synthetic fibers, utilizing technologies in fibers, nonwovens, and absorbency; its core offerings span personal care products including Huggies disposable diapers and baby wipes, Pull-Ups training pants, GoodNites bedwetting products, Kotex feminine hygiene pads, pantiliners and tampons, Poise and Depend incontinence pads, briefs and liners; consumer tissue brands such as Kleenex facial tissues, Scott, Cottonelle and Andrex toilet papers and bathroom tissues, Viva and Scott paper towels; and professional lines like WypAll utility wipes and cleaning cloths, KimWipes scientific wipes, plus soaps, sanitizers and workplace hygiene solutions under Kimberly-Clark Professional. Founded in 1872 in Neenah, Wisconsin, and headquartered in Irving, Texas, the company operates globally in more than 175 countries, serving consumers, retailers, businesses, institutions and healthcare providers through three main segments: Personal Care, Consumer Domestic and International Family Care and Professional, with manufacturing facilities across North America, Europe, Latin America and Asia. Kimberly-Clark employs approximately 40,000 people worldwide and generates annual revenues exceeding $18 billion. In recent developments, Kimberly-Clark announced in June 2025 a strategic partnership with Suzano S.A., under which it contributes substantially all assets of its International Family Care and Professional business—generating $3.3 billion in 2024 net sales across more than 70 countries, 22 facilities and 9,000 employees—for a 49% stake in a new joint venture valued at $3.4 billion, with the deal expected to close in mid-2026 and excluding its interests in Mexico and South Korea. The company is also pursuing the $48.7 billion acquisition of Kenvue Inc., announced in November 2025, which would integrate iconic brands like Tylenol, Band-Aid, Neutrogena, Aveeno, Listerine, Benadryl and Johnson's Baby into its portfolio, creating a $32 billion global health and wellness leader with projected synergies of $2.1 billion. Complementing these moves, Kimberly-Clark committed over $2 billion through 2030 to expand North American manufacturing—including a new facility in Warren, Ohio, and upgrades in Beech Island, South Carolina, plus a $130 million production line addition in Mobile, Alabama—aimed at boosting capacity for Huggies, Kleenex, Depend, Scott and Cottonelle amid rising demand, while advancing supply chain automation and innovation as part of its broadest transformation in 150 years.
Kimberly-Clark Announces $10 Million Commitment to Support Wisconsin's Fox Valley Tornado Relief and Recovery
5 Dividend Kings Continued to Pay and Raise Dividends Through Every Market Crash Since Black Monday
Delta Global Management LP Invests $990,000 in Kimberly-Clark Corporation $KMB
3 Dividend Stocks Baby Boomers Should Own for the Rest of Their Lives
An Overlooked Dividend King With a 54-Year Winning Streak Worth Buying Now
Historic High Yield - Winners 6.7% To 4% Dividend Yield
Can Kimberly-Clark's Innovation Strategy Boost Sales Growth?
4 Dividend Kings Are Crushing the S&P 500 in 2026 and Still Have Big Upside Potential
Church & Dwight vs. Kimberly-Clark: Which Consumer Goods Stock Is a Better Buy in 2026?
This 4.5%-Yielding Dividend Stock Is Beating the S&P 500 and the Nasdaq. 3 Reasons That Can Continue in the Second Half of 2026
2 Dividend Kings to Buy and Hold Forever
Kimberly-Clark to Announce Second Quarter 2026 Results on August 4, 2026
Kimberly-Clark: Pricing Attracts New Customer, But Hurts Margins (Downgrade)
Can Kimberly-Clark's Productivity Offset Rising Input Costs?
5 Underperforming Dividend Kings Offer Big Passive Income and Huge Total Return Potential
Kimberly-Clark Is Now My Largest Non-Commodities-Related Stock Position
Introducing Arbex: a New Global Leader in Tissue and Hygiene
Kimberly-Clark's 80% Payout Ratio: Balance Sheet Says Retirees Shouldn't Be Scared
5 High-Yielding Dividend Kings Retirees and Boomers Can Buy Today and Safely Hold Forever
3 Monster Dividend Stocks to Hold for the Next 10 Years